12 Month Challenge – Daisy Harris

Daisy Harris  is doing 12 runs from this April until April 2019 in memory of her Mother. Raising money for the Centre over the year. She has already done her first challenge earlier in the month.
Her fundraising page link is as follows: https://uk.virginmoneygiving.com/SomeoneSpecial/Sharon_Heather
Here is the link to her blog if you wish to keep updated on her activities: www.writingsofawildflower.co.uk.

Miles to run London Marathon for MS Therapy

London-marathon-photo-626785-edited.jpg
Miles Jones to run the London Marathon!
On 22nd April 2018, MEPC’s Development Manager – Miles Jones – is running the London Marathon to raise money and awareness for the MS Therapy Centre, based at Milton Park. Join us in cheering him along, show your support and donate to raise money for this great charity.
The Oxfordshire MS Therapy Centre provide affordable and accessible therapy sessions, as well as information and a support system for those suffering with MS. They have been a long term occupier at Milton Park and have been a nominated charity of ours for many years now.
Miles’ training is in full swing with only 7 weeks to go!

To show your support – help Miles and Milton Park to reach their fundraising target of £1500! Donations can be made here.

Thank you in advance for your kindness and generosity. Join us in cheering Miles along and watch this space for more information.

The Milton Park Team

www.miltonpark.co.uk
MEPC Ltd, Innovation Centre, 99 Park Drive, Abingdon, Oxfordshire, OX14 4RY
T: 01235 865555 E: enquiries@miltonpark.co.uk
This email was distributed on behalf of MEPC Limited Registered Office: 4th Floor, Lloyds Chambers, 1 Portsoken Street, London E1 8LW. Registered in England No. 5514581
To unsubscribe from this email, please click here.

100 club March Winners

Linda Tierney, Sarah Chapell, Nandi Ablett,  winning a share of £95 between them.

You have got to be in it to win it! Ask Reception for details……

Daclizumab withdrawn from NHS after safety concerns

Source MS Society:

Disease modifying therapy daclizumab (Zinbryta) has been withdrawn from sale worldwide. Its manufacturers took the decision after reports that a number of people taking the treatment developed serious inflammatory brain disorders.

Daclizumab will no longer be available on the NHS. All clinical trials involving the treatment will be stopped.  Read on.

HSCT works for people with relapsing MS who don’t respond to existing DMTs

Source BBC:

Doctors say a stem cell transplant could be a “game changer” for many patients with multiple sclerosis.

Results from an international trial show that it was able to stop the disease and improve symptoms. It involves wiping out a patient’s immune system using cancer drugs and then rebooting it with a stem cell transplant.

Louise Willetts, 36, from Rotherham, is now symptom-free and told me: “It feels like a miracle.”

A total of 100,000 people in the UK have MS, which attacks nerves in the brain and spinal cord.  Just over 100 patients took part in the trial, in hospitals in Chicago, Sheffield, Uppsala in Sweden and Sao Paulo in Brazil.  They all had relapsing-remitting MS – where attacks or relapses are followed by periods of remission.

The interim results were released at the annual meeting of the European Society for Bone and Marrow Transplantation in Lisbon.  Read on.

MS drug hope

Source BBC: MS drug hope for secondary-progressive stage. A study of a new drug to treat advanced cases of multiple sclerosis suggests it may be possible to delay progression of the disease in the short term, although the effects were small.

n a trial of 1,327 people, in The Lancet, 26% saw their disability worsen after three months taking siponimod compared with 32% taking a dummy drug.

No drugs currently exist for secondary-progressive multiple sclerosis.

An MS expert expressed caution, saying other new treatments were still needed.

About 100,000 people in the UK have MS – a lifelong, progressive condition. Most are diagnosed between the ages of 20 and 70. Read on.

Caroline Wyatt – My quest to stop MS in its tracks

Source BBC: A year on from gruelling stem cell treatment for her multiple sclerosis, BBC correspondent Caroline Wyatt reveals what effect the potentially life-changing “reboot” of her immune system has had on her life.

The results of an international trial show stem cell transplants can vastly improve the lives of some people with multiple sclerosis.

The gruelling treatment involves wiping out a patient’s faulty immune system with drugs used to treat cancer – and then rebuilding it using stem cell transplants.

The BBC’s Caroline Wyatt, who was deemed unsuitable for a trial in the UK, paid for a stem cell transplant in Mexico.  Read her story here.